Literature DB >> 19795911

Weighted equation and rules--a novel concept for evaluating protein-ligand interaction.

Calvin Yu-Chian Chen1.   

Abstract

In this study, a novel methodology for evaluating protein-ligand interaction and quantitated the traditional Chinese medicine (TCM) by Yin-Yang theory are proposed and investigated by a case report of the human epidermal growth factor receptor 2 (HER2)-ligand. Inhibitors (n =176) of HER2 from references with a broad range of activities (IC(50)) were employed to the docking program to calculate the binding affinities. The docking score of twelve scoring functions versus actual pIC(50) plot were regressed. According to the weighted rules, the coefficient of determinations (R(2)) from the regression analysis of each scoring function and pIC(50) were chosen as the weights in the weighted equation. The R(2) (0.5858) of weighted score (WS) versus actual pIC(50) was statistically higher than that of the consensus score (CS) (R(2) = 0.2441). The WS method lies in combining the scoring functions from different algorithms to evaluate the sum of binding affinities that is more comprehensive than any single scoring function can achieve. The WS calculated by equation successfully shows a statically significant correlation with good predictability. Thus, this methodology might provide a persuasive virtual screening criterion to evaluate the protein-ligand interaction and quantitative analysis of the functions for Chinese medicine in the future.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19795911     DOI: 10.1080/07391102.2009.10507315

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  18 in total

1.  Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic.

Authors:  Sashikanth Banappagari; Miriam Corti; Seth Pincus; Seetharama Satyanarayanajois
Journal:  J Biomol Struct Dyn       Date:  2012-06-26

2.  A conformationally constrained peptidomimetic binds to the extracellular region of HER2 protein.

Authors:  Sashikanth Banappagari; Sharon Ronald; Seetharama D Satyanarayanajois
Journal:  J Biomol Struct Dyn       Date:  2010-12

3.  Insight into molecular dynamics simulation of BRAF(V600E) and potent novel inhibitors for malignant melanoma.

Authors:  Hsin-Chieh Tang; Yu-Chian Chen
Journal:  Int J Nanomedicine       Date:  2015-04-23

4.  Possible inhibitor from traditional Chinese medicine for the β form of calcium-dependent protein kinase type II in the treatment of major depressive disorder.

Authors:  Tzu-Chieh Hung; Wen-Yuan Lee; Kuen-Bao Chen; Hung-Jin Huang; Yueh-Chiu Chan; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

5.  Insight into HIV of IFN-induced myxovirus resistance 2 (MX2) expressed by traditional Chinese medicine.

Authors:  Tzu-Chieh Hung; Wen-Yuan Lee; Kuen-Bao Chen; Yueh-Chiu Chan; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

6.  Investigation of the novel lead of melanocortin 1 receptor for pigmentary disorders.

Authors:  Hsin-Chieh Tang; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-17       Impact factor: 2.629

7.  Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptor.

Authors:  Kuen-Bao Chen; Hsin-Yi Chen; Kuan-Chung Chen; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

8.  In silico design for adenosine monophosphate-activated protein kinase agonist from traditional chinese medicine for treatment of metabolic syndromes.

Authors:  Hsin-Chieh Tang; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-11       Impact factor: 2.629

9.  Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine.

Authors:  Hung-Jin Huang; Tung-Ti Chang; Hsin-Yi Chen; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-18       Impact factor: 2.629

10.  Lead screening for HIV-1 integrase (IN) inhibited by traditional Chinese medicine.

Authors:  Tzu-Chieh Hung; Wen-Yuan Lee; Kuen-Bao Chen; Yueh-Chiu Chan; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.